Photochemotherapy for Recalcitrant Erythema Annulare Centrifugum: A Promising Treatment Option?

  • Bruno Duarte Dermatology Department, Hospital de Santo António dos Capuchos – Centro Hospitalar de Lisboa Central, Lisbon, Portugal
  • Filipa Rocha Páris Dermatology Department, Hospital de Santo António dos Capuchos – Centro Hospitalar de Lisboa Central, Lisbon, Portugal
  • Joana Cabete Dermatology Department, Hospital de Santo António dos Capuchos – Centro Hospitalar de Lisboa Central, Lisbon, Portugal
Keywords: Erythema/therapy, Photochemotherapy

Abstract

Erythema annulare centrifugum is a dermatosis of unknown aetiology which usually follows a self-limiting course. Nevertheless, some cases tend to chronicity, especially when a culprit stimulus is not found, and can be challenging to treat. A 24-year-old male presented with a 3-year history of persistent plaques with polycyclic outlines and an infiltrated rim on the forearms, buttocks and thighs. After histopathological correlation, a diagnosis of erythema annulare centrifugum was therein made. Secondary causes were ruled out. Treatment with topical and systemic steroids provided no benefit, and the patient was reluctant to further systemic oral immunosuppression. Photochemotherapy was then attempted. A marked improved was observed since the first session, and the patient was clear by the 7th treatment. No adverse events were noted. The patient is still in remission at the 3rd month of follow-up. To our knowledge, we report the first case of an erythema annulare centrifugum successfully treated with photochemotherapy. Our case highlights the potential of this time-honoured therapeutic modality to address chronic and debilitating cases of this figurate dermatosis.

Downloads

Download data is not yet available.

References

Chuang F, Lin S, Wu W. Erythromycin as a safe and effective

treatment option for erythema annulare centrifugum. Indian J Dermatol. 2015;60:519.

Minni J, Sarro R. A novel therapeutic approach to

erythema annulare centrifugum. J Am Acad Dermatol.

;54(3 SUPPL. 2):134-5. doi:10.1016/j.

jaad.2005.10.058.

Phillips WG, Ramsay ID, Breathnach SM. Erythema annulare

centriftigum unresponsive to immunosuppressive.

Br J Dermatol. 1994;131:587.

De Aloe G, Rubegni P, Risulo M, Sbano P, Poggiali S, Fimiani

M. Erythema annulare centrifugum successfully treated

with metronidazole. Clin Exp Dermatol. 2005;30:583-

doi:10.1111/j.1365-2230.2005.01796.x.

Koh W, Liu T. Erythema annulare centrifugum: food for

thought. J Am Acad Dermatol. 2015;72(Suppl 1):AB47.

doi:10.1016/j.jash.2015.03.144.

Nakamura M, Farahnik B, Bhutani T. Recent advances

in phototherapy for psoriasis. F1000Research.

;5:1684. doi:10.12688/f1000research.8846.1.

Reuter J, Braun-Falco M, Termeer C, Bruckner-Tuderman

L. Erythema anulare centrifugum Darier. Der Hautarzt.

;58:146-8. doi:10.1007/s00105-006-1131-x.

Colonel-Pérz I, Morillo-Andújar M. Erythema Annulare

centrifugum responding to natural ultraviolet light eritema.

Actas Dermosiiliogr. 2010;101:177-8.

Kim DH, Lee JH, Lee JY, Park YM. Erythema annulare

centrifugum: Analysis of associated diseases and clinical

outcomes according to histopathologic classification.

Ann Dermatol. 2016;28:257-9. doi:10.5021/

ad.2016.28.2.257.

Vangipuram R, Feldman SR. Ultraviolet phototherapy

for cutaneous diseases: A concise review. Oral Dis.

;22:253-9. doi:10.1111/odi.12366.

Archier E., Devaux S, Castela E., et al. Efficacy of Psoralen

UV-A therapy vs. Narrowband UV-B therapy in

chronic plaque psoriasis : a systematic literature review.

J Eur Acad Dermatol Venereol. 2012;26:11-21.

doi:10.1111/j.1468-3083.2012.04519.x.

Gniadecki R. Calcipotriol for erythema annulare centrifugum.

Br J Dermatol. 2002;146:317-9. doi:10.1046/

j.0007-0963.2001.04572.x.

Published
2018-10-05
How to Cite
Duarte, B., Rocha Páris, F., & Cabete, J. (2018). Photochemotherapy for Recalcitrant Erythema Annulare Centrifugum: A Promising Treatment Option?. Journal of the Portuguese Society of Dermatology and Venereology, 76(3), 313-316. https://doi.org/10.29021/spdv.76.3.895
Section
Case Reports